Skip to main content
Pharmadrug Inc. logo

Pharmadrug Inc. — Investor Relations & Filings

Ticker · PHRX ISIN · CA71716W2040 LEI · 529900PHQPAWL5ITEB39 CSE Manufacturing
Open in API
Filings indexed 475 across all filing types
Latest filing 2023-10-27 M&A Activity
Country CA Canada
Listing CSE PHRX

About Pharmadrug Inc.

https://pharmadrug.ca/

Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that PharmaDrug Inc. has entered into a definitive agreement to acquire SecureDose Synthetics. It details the terms of the acquisition, conditions precedent, and some management changes related to the transaction. There is no financial data, quarterly or annual results, or detailed financial analysis. The document is focused on the announcement of a merger/acquisition transaction rather than the merger filing itself (such as a Form 425 or DEFM14A). It is not a regulatory filing or a report publication announcement. The content fits best under the category of M&A Activity, which covers announcements and documents related to merger proposals or takeover bids.
2023-10-27 English
Certificate and Articles of Amendment.pdf
Regulatory Filings
2023-10-24 English
News release - English.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a press release announcing a share consolidation (a capital change) and a change in the Chief Financial Officer (senior management). It details the consolidation ratio, effective and record dates, new trading information, and the appointment of a new CFO. There are no financial statements or detailed financial data presented, nor is this a report or transcript. The primary content is about capital structure change and management update. According to the filing definitions, announcements about share consolidations fall under Share Issue/Capital Change (SHA), and announcements about management changes fall under Board/Management Information (MANG). However, since the document combines both but the share consolidation is the primary corporate action and the management change is secondary, the best fitting category is Share Issue/Capital Change (SHA). The document length is 7688 characters, which is sufficient for a full announcement rather than a brief note. Therefore, the classification is SHA with high confidence.
2023-10-20 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in the company's board of directors, specifically that Mr. Daniel Cohen will not stand for re-election and Mr. Robert J. Steen will replace him. It provides detailed biographical and legal background information about the new director nominee and references the company's Management Information Circular. The document does not contain financial statements, earnings data, or detailed management discussion of financial results. It is focused on board/management changes and related disclosures. Therefore, it fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a proxy solicitation but a substantive announcement about management changes.
2023-09-19 English
News release - English.pdf
Regulatory Filings
2023-09-14 English
Other.pdf
Regulatory Filings
2023-09-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.